Work

Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-134938

Authors: John F. Seymour, John G. Gribben, Matthew S. Davids, Anthony Mato, Jeff P Sharman, Aimee Cyr, Cynthia Bartkus, German Pena, Michelle Boyer, Simon Sharmokh, Tanya S Rosenberg, William G. Wierda

Institutions: The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Queen Mary University of London, Barts Health NHS Trust, Dana-Farber Cancer Institute, University of Pennsylvania, Willamette Valley Cancer Institute and Research Center, AbbVie (United States), Genentech, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3094829169

FWCI:

Cites:

Cited by: 5

Related to: 10